Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 20, 2020
Previous Article Next Article

Magnetite mesoporous silica nanoparticles embedded in carboxybetaine methacrylate for application in hyperthermia and drug delivery

Author affiliations

Abstract

Magnetite mesoporous silica nanoparticles (MMSNs) are biocompatible and can easily deliver a drug to the target tissue, but there are two challenges: burst effect and protein corona. In this study, poly(carboxybetaine methacrylate) (pCBMA) coating was used for MMSNs because pCBMA inhibits protein uptake. Tamoxifen is loaded onto magnetite mesoporous silica nanoparticles and then embedded in pCBMA nanogels. The drug release was studied for 125 h at temperatures of 37 and 43 °C and pH values of 6.7 and 7.4. Our results show that less than 20% of the drug is released within 24 hours for all samples. MTT assay was performed to determine the biocompatibility of the nanogels. The results show that nanogels are biocompatible at high concentrations. The growth and proliferation of L929 cells after 72 hours were studied. In this study, hyperthermia (in vitro) was investigated and the nanogels showed good heat production capability.

Graphical abstract: Magnetite mesoporous silica nanoparticles embedded in carboxybetaine methacrylate for application in hyperthermia and drug delivery

Back to tab navigation

Supplementary files

Article information


Submitted
23 Feb 2020
Accepted
05 Apr 2020
First published
13 Apr 2020

New J. Chem., 2020,44, 8232-8240
Article type
Paper

Magnetite mesoporous silica nanoparticles embedded in carboxybetaine methacrylate for application in hyperthermia and drug delivery

H. Keshavarz, A. Khavandi, S. Alamolhoda and M. R. Naimi-Jamal, New J. Chem., 2020, 44, 8232
DOI: 10.1039/D0NJ00939C

Social activity

Search articles by author

Spotlight

Advertisements